BIO-TECHNE Corp·4

Nov 3, 5:23 PM ET

Klimovsky Judith V. 4

4 · BIO-TECHNE Corp · Filed Nov 3, 2025

Insider Transaction Report

Form 4
Period: 2025-10-30
Transactions
  • Award

    Common Stock

    2025-10-30+1,6403,782 total
  • Award

    Stock Option (Right to Buy)

    2025-10-30+3,7773,777 total
    Exercise: $60.96Exp: 2035-10-30Common Stock (3,777 underlying)
Holdings
  • Stock Option (Right to Buy)

    Exercise: $73.46From: 2024-10-24Exp: 2034-05-01Common Stock (1,610 underlying)
    1,610
  • Stock Option (Right to Buy)

    Exercise: $68.37From: 2025-10-24Exp: 2034-10-24Common Stock (3,511 underlying)
    3,511
Footnotes (1)
  • [F1]The option vests on the earlier of the one year anniversary of the grant date (10/30/2025) or the date of Bio-Techne's 2026 annual meeting of shareholders.

Documents

1 file
  • 4
    form4.xmlPrimary

    STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES